Systemic Lupus Erythematosus (SLE) is a chronic systemic disease with various clinical manifestations. It is characterized by episodic and unpredictable exacerbations and by remissions, usually associated with treatment. The challenge to rheumatologists is to reliably measure new and/or increasing disease activity, so that they can prevent permanent organ damage and premature death with timely treatment. Several reliable and valid clinical activity indices including Lupus Activity Index (LAI), Systemic Lupus Erythematosus Activity Index (SLEDAI) and Systemic Lupus Activity Measure (SLAM) exist. However,no single laboratory parameter to date has proven sufficiently reliable and valid for disease activity in SLE. Our goal is to determine the predictive value for activity/flare (using valid and reliable clinical disease activity indices:LAI, SLEDAI and SLAM) of currently available serologic tests(i.e. sedimentation rate, double-stranded DNA and complement levels) and investigational assays such as complement split products, in a longitudinal regression model that adjusts for demographic, clinical and treatment variables. The Hopkins Lupus cohort offers a unique, prospective database of demographic, social, clinical and laboratory measures that can be used to determine laboratory tests which can reliably predict disease activity and flare especially in different organ systems. This cohort began in 1987 and consists presently of 411 living patients. It is an ongoing prospective study in which SLE patients are followed by protocol with visits every 3 months. The cohort is racially balanced with over one half of the members being Afro-American and reflects a broad socioeconomic range.
| Robert Braši?, James; Mari, Zoltan; Lerner, Alicja et al. (2018) Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration. Int J Phys Med Rehabil 6: |
| Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866 |
| AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786 |
| Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671 |
| Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72 |
| Al-Sofiani, Mohammed E; Yanek, Lisa R; Faraday, Nauder et al. (2018) Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab 103:4599-4608 |
| Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429 |
| Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451 |
| Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504 |
| Aboud, Katherine S; Barquero, Laura A; Cutting, Laurie E (2018) Prefrontal mediation of the reading network predicts intervention response in dyslexia. Cortex 101:96-106 |
Showing the most recent 10 out of 1014 publications
